12-66189300-A-G
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 1P and 6B. PVS1_SupportingBP6_ModerateBS2
The NM_007199.3(IRAK3):c.1A>G(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000211 in 1,536,240 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00040 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00019 ( 2 hom. )
Consequence
IRAK3
NM_007199.3 start_lost
NM_007199.3 start_lost
Scores
4
4
8
Clinical Significance
Conservation
PhyloP100: 1.80
Publications
0 publications found
Genes affected
IRAK3 (HGNC:17020): (interleukin 1 receptor associated kinase 3) This gene encodes a member of the interleukin-1 receptor-associated kinase protein family. Members of this family are essential components of the Toll/IL-R immune signal transduction pathways. This protein is primarily expressed in monocytes and macrophages and functions as a negative regulator of Toll-like receptor signaling. Mutations in this gene are associated with a susceptibility to asthma. Alternate splicing results in multiple transcript variants. [provided by RefSeq, May 2010]
IRAK3 Gene-Disease associations (from GenCC):
- asthma-related traits, susceptibility to, 5Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
PVS1
Start lost variant, no pathogenic variants between lost start and next in-frame start position. Next in-frame start position is after 93 codons. Genomic position: 66203854. Lost 0.155 part of the original CDS.
BP6
Variant 12-66189300-A-G is Benign according to our data. Variant chr12-66189300-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 736195.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 61 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRAK3 | ENST00000261233.9 | c.1A>G | p.Met1? | start_lost | Exon 1 of 12 | 1 | NM_007199.3 | ENSP00000261233.4 | ||
IRAK3 | ENST00000545837.1 | c.1A>G | p.Met1? | start_lost | Exon 1 of 2 | 1 | ENSP00000441321.1 | |||
IRAK3 | ENST00000457197.2 | c.1A>G | p.Met1? | start_lost | Exon 1 of 11 | 2 | ENSP00000409852.2 |
Frequencies
GnomAD3 genomes AF: 0.000401 AC: 61AN: 152194Hom.: 1 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
61
AN:
152194
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000204 AC: 27AN: 132448 AF XY: 0.000206 show subpopulations
GnomAD2 exomes
AF:
AC:
27
AN:
132448
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000190 AC: 263AN: 1383928Hom.: 2 Cov.: 31 AF XY: 0.000184 AC XY: 126AN XY: 683186 show subpopulations
GnomAD4 exome
AF:
AC:
263
AN:
1383928
Hom.:
Cov.:
31
AF XY:
AC XY:
126
AN XY:
683186
show subpopulations
African (AFR)
AF:
AC:
1
AN:
31698
American (AMR)
AF:
AC:
0
AN:
35894
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25090
East Asian (EAS)
AF:
AC:
1
AN:
36034
South Asian (SAS)
AF:
AC:
0
AN:
79410
European-Finnish (FIN)
AF:
AC:
140
AN:
33598
Middle Eastern (MID)
AF:
AC:
0
AN:
4742
European-Non Finnish (NFE)
AF:
AC:
103
AN:
1079698
Other (OTH)
AF:
AC:
18
AN:
57764
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
13
26
38
51
64
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.000400 AC: 61AN: 152312Hom.: 1 Cov.: 33 AF XY: 0.000497 AC XY: 37AN XY: 74490 show subpopulations
GnomAD4 genome
AF:
AC:
61
AN:
152312
Hom.:
Cov.:
33
AF XY:
AC XY:
37
AN XY:
74490
show subpopulations
African (AFR)
AF:
AC:
7
AN:
41582
American (AMR)
AF:
AC:
1
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5172
South Asian (SAS)
AF:
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
AC:
37
AN:
10614
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
16
AN:
68014
Other (OTH)
AF:
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
33
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Mar 30, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
DANN
Benign
DEOGEN2
Benign
T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Benign
T
PhyloP100
PROVEAN
Benign
N;N;N
REVEL
Uncertain
Sift
Pathogenic
D;D;D
Sift4G
Pathogenic
D;D;D
Polyphen
B;B;B
Vest4
MutPred
Gain of catalytic residue at C5 (P = 0.0011);Gain of catalytic residue at C5 (P = 0.0011);Gain of catalytic residue at C5 (P = 0.0011);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.